Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Dowlais Group (DWL) by Jefferies
- Buy Norcros (NXR) by Berenberg
- Buy Volex (VLX) by Tom Winnifrith in ShareProphets
- Buy Volex (VLX) by Steve Moore in ShareProphets
- Buy Origin Enterprises (CDI) (OGN) by Shore Capital
- Buy Victorian Plumbing Group (VIC) by Shore Capital
- Avoid Cropper (James) (CRPR) by Steve Moore in ShareProphets
- Buy Close Brothers Group (CBG) by Shore Capital
- Buy WH Smith (SMWH) by Canaccord Genuity
- Hold Halma (HLMA) by Shore Capital
- Buy Speedy Hire (SDY) by Canaccord Genuity
- Buy Norcros (NXR) by Shore Capital
- Buy XPS Pensions Group (XPS) by Canaccord Genuity
- Hold CMC Markets (CMCX) by Shore Capital
- Hold Warehouse Reit (WHR) by Shore Capital
- Buy Jet2 (JET2) by Canaccord Genuity
- Underperform Halma (HLMA) by Jefferies
- Avoid Churchill China (CHH) by Steve Moore in ShareProphets
- Buy Sage Group (SGE) by Bank of America
- Hold JD Sports Fashion (JD.) by Harvey Jones in The Motley Fool
Faron Pharmaceuticals Oy (DI) (FARN) Share Price
Health Care Sector
NOTE: This is based on 3 open tips for Faron Pharmaceuticals Oy (DI) (FARN)
| Latest Bid : 140.00p | Latest Ask : 145.00p |
| High Today : 148.00p | Low Today : 140.00p |
| This Years High : 350.00p | This Years Low : 92.50p |
| Volume : 6,706 | MKT Cap : £148.2M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Faron Pharmaceuticals Oy (DI) (FARN) Overview
We are a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system in order to tackle cancer and inflammation. Since our founding in 2007, our goal has been to develop a diverse and unique pipeline rooted in high quality science and innovation. Faron is focused on mastering immune modulation by harnessing endothelial receptors to control and mediate immune responses.Faron Pharmaceuticals Oy (DI) (FARN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Under Review | Panmure Gordon | Premium Only | 2020-02-07 09:15:00 07/02/2020 | – |
| Buy | Panmure Gordon | Premium Only | 2017-09-07 08:30:00 07/09/2017 | 0.69% |
| Buy | Panmure Gordon | Premium Only | 2017-02-20 14:40:00 20/02/2017 | -37.67% |
Faron Pharmaceuticals Oy (DI) (FARN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 140.00p | Latest Ask : 145.00p |
| High Today : 148.00p | Low Today : 140.00p |
| This Years High : 350.00p | This Years Low : 92.50p |
| Volume : 6,706 | MKT Cap : £148.2M |
Faron Pharmaceuticals Oy (DI) Overview
We are a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system in order to tackle cancer and inflammation. Since our founding in 2007, our goal has been to develop a diverse and unique pipeline rooted in high quality science and innovation. Faron is focused on mastering immune modulation by harnessing endothelial receptors to control and mediate immune responses.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Faron Pharmaceuticals Oy (DI) Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Under Review | Panmure Gordon | Premium Only | 2020-02-07 09:15:00 07/02/2020 | – |
| Buy | Panmure Gordon | Premium Only | 2017-09-07 08:30:00 07/09/2017 | 0.69% |
| Buy | Panmure Gordon | Premium Only | 2017-02-20 14:40:00 20/02/2017 | -37.67% |